|
Compounds to Treat Obesity (104-010)
Obesity is now considered as a global epidemic with over one billion people being overweight. About $33 billion is being spent each year in USA on weight reduction products. To date no satisfactory drug is available to control obesity. Therefore, millions of dollars are spent each year towards the development of new treatments to fight this epidemic.
Neuropeptide...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Ambikaipakan Balasubramanium
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Therapeutics > Biomaterials, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Diseases & Disorders > Cardiovascular, Technology Classifications > Life Sciences > Diseases & Disorders > Diabetes-related
|
|
Breath analysis for disease diagnosis
Subtitle
Image*
[UPLOAD IMAGE HERE]
https://uc.technologypublisher.com/files/sites/images_medium_ac-2017-038087_00091.gif
Description*
Drs. Anastasios Angelopoulos and Jonathan A. Bernstein have developed a new optical sensor that could enable nearly instantaneous chemical measurement of human breath. The tool is simple and non-invasive, which...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Jonathan Bernstein, Anastasios Angelopoulos
Keywords(s): Biological Biomarker, Breath Analysis, Chemical Detection, Disease Diagnosis, Healthcare
Category(s): Technology Classifications > Sensors > Health-related Sensors, Technology Classifications > Sensors > Agribusiness-Environmental, Technology Classifications > Life Sciences > Diseases & Disorders > Diabetes-related, Technology Classifications > Sensors, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders
|
|
Potential Type 1 diabetes therapy (113-077)
Investigators at the University of Cincinnati have found a therapy that reverses new onset Type 1 diabetes in mouse models and may advance efforts in combating the disease among humans.
Type 1 diabetes (T1D) is an autoimmune disease affecting millions of people world-wide, and is currently incurable. Moreover, since the mid-20th century, the incidence...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): William Ridgway
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Therapeutics > Protein Therapies, Technology Classifications > Life Sciences > Diseases & Disorders > Diabetes-related, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Therapeutics
|
|
Novel Therapy for Type I Diabetes (110-077)
Dr. William Ridgway has found a potential new therapy for Type I diabetes.
T regulatory cells are very powerful down modulators of immune responses. We for the first time have shown that CD137pos cells are functionally and phenotypically different than normal Tregs and are more suppressive of immune function. In addition, we have now shown that CD137pos...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): William Ridgway
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diseases & Disorders > Diabetes-related, Technology Classifications > Life Sciences > Therapeutics > Protein Therapies, Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Diseases & Disorders, Technology Classifications > Life Sciences > Therapeutics
|